利凡斯的明: Difference between revisions
From SEHK Wiki
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
利凡斯的明(Rivastigmine)是一種可逆轉的乙酰膽鹼酯酶抑製劑。 | 利凡斯的明(Rivastigmine)是一種可逆轉的乙酰膽鹼酯酶抑製劑。 | ||
此藥針對中樞神經系統，用於治療患有帕金森症伴隨的輕度至中度認知障礙症 ; 協助改善患者的日常生活、方行為和認知能力。 | 此藥針對中樞神經系統，用於治療患有帕金森症伴隨的輕度至中度認知障礙症 ; 協助改善患者的日常生活、方行為和認知能力。 | ||
==讀音== | |||
{| class="wikitable" | |||
!Generic Name | |||
藥名 | |||
!HA Code 藥物代碼 | |||
!Classification藥物分類 | |||
|- | |||
|Rivastigmine Cap 1.5 mg | |||
|RIVA01 | |||
|P1S1S3 | |||
|- | |||
|Rivastigmine Cap 3 mg | |||
|RIVA02 | |||
|P1S1S3 | |||
|- | |||
|Rivastigmine Cap 4.5 mg | |||
|RIVA03 | |||
|P1S1S3 | |||
|- | |||
|Rivastigmine Cap 6 mg | |||
|RIVA04 | |||
|P1S1S3 | |||
|- | |||
|Rivastigmine Transdermal | |||
patch 4.6mg/24hr | |||
|RIVA05 | |||
|P1S1S3 | |||
|- | |||
|Rivastigmine Transdermal | |||
patch 9.5mg/24hr | |||
|RIVA06 | |||
|P1S1S3 | |||
|- | |||
|Rivastigmine Transdermal | |||
patch 13.3mg/24hr | |||
|RIVA10 | |||
|P1S1S3 | |||
|} | |||
Revision as of 21:36, 6 October 2020
引言
利凡斯的明(Rivastigmine)是一種可逆轉的乙酰膽鹼酯酶抑製劑。 此藥針對中樞神經系統，用於治療患有帕金森症伴隨的輕度至中度認知障礙症 ; 協助改善患者的日常生活、方行為和認知能力。
讀音
| Generic Name
藥名 |
HA Code 藥物代碼 | Classification藥物分類 |
|---|---|---|
| Rivastigmine Cap 1.5 mg | RIVA01 | P1S1S3 |
| Rivastigmine Cap 3 mg | RIVA02 | P1S1S3 |
| Rivastigmine Cap 4.5 mg | RIVA03 | P1S1S3 |
| Rivastigmine Cap 6 mg | RIVA04 | P1S1S3 |
| Rivastigmine Transdermal
patch 4.6mg/24hr |
RIVA05 | P1S1S3 |
| Rivastigmine Transdermal
patch 9.5mg/24hr |
RIVA06 | P1S1S3 |
| Rivastigmine Transdermal
patch 13.3mg/24hr |
RIVA10 | P1S1S3 |
